Status:
UNKNOWN
Antibody Levels Against 2009 Influenza A H1N1 One Year After Vaccination With Pandemrix and 2010 Fluarix Booster in Organ Transplant Recipients.
Lead Sponsor:
Sahlgrenska University Hospital
Conditions:
Organ Transplantation
Eligibility:
All Genders
18-80 years
Brief Summary
Organ transplant patients who participated in a retrospective study and received 2009 Pandemrix vaccine during autumn 2009 are included in this study. The main aim is to determine the H1N1 antibody l...
Detailed Description
Organ transplant patients and staff members of the Transplant Institute who were vaccinated 2009 and received 2 doses of 2009 H1N1 influenza vaccine (Pandemrix) will be asked to participate in the stu...
Eligibility Criteria
Inclusion
- Inclusion Criteria Cohort number 1: Organ transplant patients who were vaccinated with Pandemrix 2009 and written informed consent received
- Cohort number 2: Staff members who were vaccinated with Pandemrix 2009 and written informed consent received
- Exclusion Criteria:
- Patients or controls who are allergic to formaldehyde, gentamycin sulphate or natrium deoxycholate or have other contraindications against to Fluarix vaccination.
Exclusion
Key Trial Info
Start Date :
December 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
110 Patients enrolled
Trial Details
Trial ID
NCT01256931
Start Date
December 1 2010
Last Update
December 9 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Transplant Institute, Sahlgrenska University Hospital
Gothenburg, Västra Götaland County, Sweden